Skip to main content
Erschienen in: The International Journal of Cardiovascular Imaging 10/2017

24.04.2017 | Original Paper

Myocardial salvage after primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction presenting early versus late after symptom onset

verfasst von: Thomas Stiermaier, Ingo Eitel, Suzanne de Waha, Janine Pöss, Georg Fuernau, Holger Thiele, Steffen Desch

Erschienen in: The International Journal of Cardiovascular Imaging | Ausgabe 10/2017

Einloggen, um Zugang zu erhalten

Abstract

Primary percutaneous coronary intervention (PCI) is the treatment of choice in patients with ST-elevation myocardial infarction (STEMI) presenting within 12 h of symptom onset. A benefit in the subacute stage is less clear. The aim of the present analysis was to compare myocardial salvage and infarct size between patients with early and late reperfusion after STEMI. We compared cardiac magnetic resonance (CMR) data from a randomized controlled trial (RCT) in STEMI patients presenting within 12 h (n = 695) and a RCT of subacute STEMI patients presenting between 12 and 48 h (n = 93) after symptom onset. CMR imaging was performed 3.9 ± 6.3 days after myocardial infarction. Analyses were performed for an unmatched cohort comprising all patients (n = 788) and a cohort matched for area at risk (n = 186). In the overall cohort, area at risk was similar in both groups [37.1 ± 16.1% of left ventricular mass (%LV) vs. 38.3 ± 16.2%LV; p = 0.50]. Compared to STEMI patients with early reperfusion, patients with late PCI demonstrated larger infarct size (18.0 ± 12.5%LV vs. 28.9 ± 16.9%LV; p < 0.01) and higher extent of microvascular obstruction (1.5 ± 2.9%LV vs. 2.7 ± 4.1%LV; p = 0.01). Myocardial salvage index was significantly smaller in patients with late reperfusion (52.1 ± 25.9 vs. 27.4 ± 26.0; p < 0.01). Analysis of the matched cohorts confirmed the decreased myocardial salvage (p < 0.01) and increased infarct size (p < 0.01) in case of late reperfusion. Compared to patients with timely primary PCI, late reperfusion after STEMI results in decreased myocardial salvage and increased infarct size. However, salvageable myocardium was also found in subacute stages of STEMI.
Literatur
1.
Zurück zum Zitat Reimer KA, Jennings RB (1979) The “wavefront phenomenon” of myocardial ischemic cell death. II. Transmural progression of necrosis within the framework of ischemic bed size (myocardium at risk) and collateral flow. Lab Invest 40:633–644PubMed Reimer KA, Jennings RB (1979) The “wavefront phenomenon” of myocardial ischemic cell death. II. Transmural progression of necrosis within the framework of ischemic bed size (myocardium at risk) and collateral flow. Lab Invest 40:633–644PubMed
2.
Zurück zum Zitat O’Gara PT, Kushner FG, Ascheim DD, Casey DE Jr, Chung MK, de Lemos JA et al (2013) 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 61:e78–e140CrossRefPubMed O’Gara PT, Kushner FG, Ascheim DD, Casey DE Jr, Chung MK, de Lemos JA et al (2013) 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 61:e78–e140CrossRefPubMed
3.
Zurück zum Zitat Windecker S, Kolh P, Alfonso F, Collet JP, Cremer J, Falk V et al (2014) 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 35:2541–2619CrossRefPubMed Windecker S, Kolh P, Alfonso F, Collet JP, Cremer J, Falk V et al (2014) 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 35:2541–2619CrossRefPubMed
4.
Zurück zum Zitat Schomig A, Ndrepepa G, Kastrati A (2006) Late myocardial salvage: time to recognize its reality in the reperfusion therapy of acute myocardial infarction. Eur Heart J 27:1900–1907CrossRefPubMed Schomig A, Ndrepepa G, Kastrati A (2006) Late myocardial salvage: time to recognize its reality in the reperfusion therapy of acute myocardial infarction. Eur Heart J 27:1900–1907CrossRefPubMed
5.
Zurück zum Zitat LATE Study Group (1993) Late Assessment of Thrombolytic Efficacy (LATE) study with alteplase 6–24 h after onset of acute myocardial infarction. Lancet 342:759–766CrossRef LATE Study Group (1993) Late Assessment of Thrombolytic Efficacy (LATE) study with alteplase 6–24 h after onset of acute myocardial infarction. Lancet 342:759–766CrossRef
6.
Zurück zum Zitat EMERAS (Estudio Multicentrico Estreptoquinasa Republicas de America del Sur) Collaborative Group (1993) Randomised trial of late thrombolysis in patients with suspected acute myocardial infarction. Lancet 342:767–772CrossRef EMERAS (Estudio Multicentrico Estreptoquinasa Republicas de America del Sur) Collaborative Group (1993) Randomised trial of late thrombolysis in patients with suspected acute myocardial infarction. Lancet 342:767–772CrossRef
7.
Zurück zum Zitat Schomig A, Ndrepepa G, Mehilli J, Schwaiger M, Schuhlen H, Nekolla S et al (2003) Therapy-dependent influence of time-to-treatment interval on myocardial salvage in patients with acute myocardial infarction treated with coronary artery stenting or thrombolysis. Circulation 108:1084–1088CrossRefPubMed Schomig A, Ndrepepa G, Mehilli J, Schwaiger M, Schuhlen H, Nekolla S et al (2003) Therapy-dependent influence of time-to-treatment interval on myocardial salvage in patients with acute myocardial infarction treated with coronary artery stenting or thrombolysis. Circulation 108:1084–1088CrossRefPubMed
8.
Zurück zum Zitat Busk M, Kaltoft A, Nielsen SS, Bottcher M, Rehling M, Thuesen L et al (2009) Infarct size and myocardial salvage after primary angioplasty in patients presenting with symptoms for <12 h vs. 12–72 h. Eur Heart J 30:1322–1330CrossRefPubMed Busk M, Kaltoft A, Nielsen SS, Bottcher M, Rehling M, Thuesen L et al (2009) Infarct size and myocardial salvage after primary angioplasty in patients presenting with symptoms for <12 h vs. 12–72 h. Eur Heart J 30:1322–1330CrossRefPubMed
9.
Zurück zum Zitat Schomig A, Mehilli J, Antoniucci D, Ndrepepa G, Markwardt C, Di Pede F et al (2005) Mechanical reperfusion in patients with acute myocardial infarction presenting more than 12 h from symptom onset: a randomized controlled trial. JAMA 293:2865–2872.CrossRefPubMed Schomig A, Mehilli J, Antoniucci D, Ndrepepa G, Markwardt C, Di Pede F et al (2005) Mechanical reperfusion in patients with acute myocardial infarction presenting more than 12 h from symptom onset: a randomized controlled trial. JAMA 293:2865–2872.CrossRefPubMed
10.
Zurück zum Zitat Hadamitzky M, Langhans B, Hausleiter J, Sonne C, Kastrati A, Martinoff S et al (2013) The assessment of area at risk and myocardial salvage after coronary revascularization in acute myocardial infarction: comparison between CMR and SPECT. JACC Cardiovasc Imaging 6:358–369CrossRefPubMed Hadamitzky M, Langhans B, Hausleiter J, Sonne C, Kastrati A, Martinoff S et al (2013) The assessment of area at risk and myocardial salvage after coronary revascularization in acute myocardial infarction: comparison between CMR and SPECT. JACC Cardiovasc Imaging 6:358–369CrossRefPubMed
11.
Zurück zum Zitat Francone M, Bucciarelli-Ducci C, Carbone I, Canali E, Scardala R, Calabrese FA et al (2009) Impact of primary coronary angioplasty delay on myocardial salvage, infarct size, and microvascular damage in patients with ST-segment elevation myocardial infarction: insight from cardiovascular magnetic resonance. J Am Coll Cardiol 54:2145–2153CrossRefPubMed Francone M, Bucciarelli-Ducci C, Carbone I, Canali E, Scardala R, Calabrese FA et al (2009) Impact of primary coronary angioplasty delay on myocardial salvage, infarct size, and microvascular damage in patients with ST-segment elevation myocardial infarction: insight from cardiovascular magnetic resonance. J Am Coll Cardiol 54:2145–2153CrossRefPubMed
12.
Zurück zum Zitat Thiele H, Wohrle J, Hambrecht R, Rittger H, Birkemeyer R, Lauer B et al (2012) Intracoronary versus intravenous bolus abciximab during primary percutaneous coronary intervention in patients with acute ST-elevation myocardial infarction: a randomised trial. Lancet 379:923–931CrossRefPubMed Thiele H, Wohrle J, Hambrecht R, Rittger H, Birkemeyer R, Lauer B et al (2012) Intracoronary versus intravenous bolus abciximab during primary percutaneous coronary intervention in patients with acute ST-elevation myocardial infarction: a randomised trial. Lancet 379:923–931CrossRefPubMed
13.
Zurück zum Zitat Eitel I, Wohrle J, Suenkel H, Meissner J, Kerber S, Lauer B et al (2013) Intracoronary compared with intravenous bolus abciximab application during primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: cardiac magnetic resonance substudy of the AIDA STEMI trial. J Am Coll Cardiol 61:1447–1454CrossRefPubMed Eitel I, Wohrle J, Suenkel H, Meissner J, Kerber S, Lauer B et al (2013) Intracoronary compared with intravenous bolus abciximab application during primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: cardiac magnetic resonance substudy of the AIDA STEMI trial. J Am Coll Cardiol 61:1447–1454CrossRefPubMed
14.
Zurück zum Zitat Desch S, Stiermaier T, De Waha S, Lurz P, Gutberlet M, Sandri M et al (2016) Thrombus aspiration in patients with ST-elevation myocardial infarction presenting late after symptom onset. JACC Cardiovasc Interv 9:113–122CrossRefPubMed Desch S, Stiermaier T, De Waha S, Lurz P, Gutberlet M, Sandri M et al (2016) Thrombus aspiration in patients with ST-elevation myocardial infarction presenting late after symptom onset. JACC Cardiovasc Interv 9:113–122CrossRefPubMed
15.
Zurück zum Zitat Desch S, Wohrle J, Hambrecht R, Rittger H, Birkemeyer R, Lauer B et al (2013) Intracoronary versus intravenous abciximab bolus in patients with ST-segment elevation myocardial infarction: 1-year results of the randomized AIDA STEMI trial. J Am Coll Cardiol 62:1214–1215CrossRefPubMed Desch S, Wohrle J, Hambrecht R, Rittger H, Birkemeyer R, Lauer B et al (2013) Intracoronary versus intravenous abciximab bolus in patients with ST-segment elevation myocardial infarction: 1-year results of the randomized AIDA STEMI trial. J Am Coll Cardiol 62:1214–1215CrossRefPubMed
16.
Zurück zum Zitat Thiele H, Wohrle J, Neuhaus P, Brosteanu O, Sick P, Prondzinsky R et al (2010) Intracoronary compared with intravenous bolus abciximab application during primary percutaneous coronary intervention: design and rationale of the Abciximab Intracoronary versus intravenously Drug Application in ST-Elevation Myocardial Infarction (AIDA STEMI) trial. Am Heart J 159:547–554CrossRefPubMed Thiele H, Wohrle J, Neuhaus P, Brosteanu O, Sick P, Prondzinsky R et al (2010) Intracoronary compared with intravenous bolus abciximab application during primary percutaneous coronary intervention: design and rationale of the Abciximab Intracoronary versus intravenously Drug Application in ST-Elevation Myocardial Infarction (AIDA STEMI) trial. Am Heart J 159:547–554CrossRefPubMed
17.
Zurück zum Zitat Thiele H, Kappl MJ, Conradi S, Niebauer J, Hambrecht R, Schuler G (2006) Reproducibility of chronic and acute infarct size measurement by delayed enhancement-magnetic resonance imaging. J Am Coll Cardiol 47:1641–1645CrossRefPubMed Thiele H, Kappl MJ, Conradi S, Niebauer J, Hambrecht R, Schuler G (2006) Reproducibility of chronic and acute infarct size measurement by delayed enhancement-magnetic resonance imaging. J Am Coll Cardiol 47:1641–1645CrossRefPubMed
18.
Zurück zum Zitat Yusuf S, Lopez R, Maddison A, Sleight P (1981) Variability of electrocardiographic and enzyme evolution of myocardial infarction in man. Br Heart J 45:271–280CrossRefPubMedPubMedCentral Yusuf S, Lopez R, Maddison A, Sleight P (1981) Variability of electrocardiographic and enzyme evolution of myocardial infarction in man. Br Heart J 45:271–280CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Milavetz JJ, Giebel DW, Christian TF, Schwartz RS, Holmes DR Jr, Gibbons RJ (1998) Time to therapy and salvage in myocardial infarction. J Am Coll Cardiol 31:1246–1251CrossRefPubMed Milavetz JJ, Giebel DW, Christian TF, Schwartz RS, Holmes DR Jr, Gibbons RJ (1998) Time to therapy and salvage in myocardial infarction. J Am Coll Cardiol 31:1246–1251CrossRefPubMed
20.
Zurück zum Zitat Rentrop KP, Feit F, Sherman W, Stecy P, Hosat S, Cohen M et al (1989) Late thrombolytic therapy preserves left ventricular function in patients with collateralized total coronary occlusion: primary end point findings of the Second Mount Sinai-New York University Reperfusion Trial. J Am Coll Cardiol 14:58–64CrossRefPubMed Rentrop KP, Feit F, Sherman W, Stecy P, Hosat S, Cohen M et al (1989) Late thrombolytic therapy preserves left ventricular function in patients with collateralized total coronary occlusion: primary end point findings of the Second Mount Sinai-New York University Reperfusion Trial. J Am Coll Cardiol 14:58–64CrossRefPubMed
21.
Zurück zum Zitat Kloner RA, Shook T, Antman EM, Cannon CP, Przyklenk K, Yoo K et al (1998) Prospective temporal analysis of the onset of preinfarction angina versus outcome: an ancillary study in TIMI-9B. Circulation 97:1042–1045CrossRefPubMed Kloner RA, Shook T, Antman EM, Cannon CP, Przyklenk K, Yoo K et al (1998) Prospective temporal analysis of the onset of preinfarction angina versus outcome: an ancillary study in TIMI-9B. Circulation 97:1042–1045CrossRefPubMed
22.
Zurück zum Zitat Andersen HR, Nielsen TT, Rasmussen K, Thuesen L, Kelbaek H, Thayssen P et al (2003) A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N Engl J Med 349:733–742CrossRefPubMed Andersen HR, Nielsen TT, Rasmussen K, Thuesen L, Kelbaek H, Thayssen P et al (2003) A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N Engl J Med 349:733–742CrossRefPubMed
23.
Zurück zum Zitat Boersma E (2006) Does time matter? A pooled analysis of randomized clinical trials comparing primary percutaneous coronary intervention and in-hospital fibrinolysis in acute myocardial infarction patients. Eur Heart J 27:779–788CrossRefPubMed Boersma E (2006) Does time matter? A pooled analysis of randomized clinical trials comparing primary percutaneous coronary intervention and in-hospital fibrinolysis in acute myocardial infarction patients. Eur Heart J 27:779–788CrossRefPubMed
24.
Zurück zum Zitat Ndrepepa G, Kastrati A, Mehilli J, Antoniucci D, Schomig A (2009) Mechanical reperfusion and long-term mortality in patients with acute myocardial infarction presenting 12–48 h from onset of symptoms. JAMA 301:487–488CrossRefPubMed Ndrepepa G, Kastrati A, Mehilli J, Antoniucci D, Schomig A (2009) Mechanical reperfusion and long-term mortality in patients with acute myocardial infarction presenting 12–48 h from onset of symptoms. JAMA 301:487–488CrossRefPubMed
25.
Zurück zum Zitat Hochman JS, Lamas GA, Buller CE, Dzavik V, Reynolds HR, Abramsky SJ et al (2006) Coronary intervention for persistent occlusion after myocardial infarction. N Engl J Med 355:2395–2407CrossRefPubMedPubMedCentral Hochman JS, Lamas GA, Buller CE, Dzavik V, Reynolds HR, Abramsky SJ et al (2006) Coronary intervention for persistent occlusion after myocardial infarction. N Engl J Med 355:2395–2407CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Steg PG, Thuaire C, Himbert D, Carrie D, Champagne S, Coisne D et al (2004) DECOPI (DEsobstruction COronaire en Post-Infarctus): a randomized multi-centre trial of occluded artery angioplasty after acute myocardial infarction. Eur Heart J 25:2187–2194CrossRefPubMed Steg PG, Thuaire C, Himbert D, Carrie D, Champagne S, Coisne D et al (2004) DECOPI (DEsobstruction COronaire en Post-Infarctus): a randomized multi-centre trial of occluded artery angioplasty after acute myocardial infarction. Eur Heart J 25:2187–2194CrossRefPubMed
27.
Zurück zum Zitat Abbate A, Biondi-Zoccai GG, Appleton DL, Erne P, Schoenenberger AW, Lipinski MJ et al (2008) Survival and cardiac remodeling benefits in patients undergoing late percutaneous coronary intervention of the infarct-related artery: evidence from a meta-analysis of randomized controlled trials. J Am Coll Cardiol 51:956–964CrossRefPubMed Abbate A, Biondi-Zoccai GG, Appleton DL, Erne P, Schoenenberger AW, Lipinski MJ et al (2008) Survival and cardiac remodeling benefits in patients undergoing late percutaneous coronary intervention of the infarct-related artery: evidence from a meta-analysis of randomized controlled trials. J Am Coll Cardiol 51:956–964CrossRefPubMed
28.
Zurück zum Zitat Kim HW, Van Assche L, Jennings RB, Wince WB, Jensen CJ, Rehwald WG et al (2015) Relationship of T2-weighted MRI myocardial hyperintensity and the ischemic area-at-risk. Circ Res 117:254–265CrossRefPubMedPubMedCentral Kim HW, Van Assche L, Jennings RB, Wince WB, Jensen CJ, Rehwald WG et al (2015) Relationship of T2-weighted MRI myocardial hyperintensity and the ischemic area-at-risk. Circ Res 117:254–265CrossRefPubMedPubMedCentral
Metadaten
Titel
Myocardial salvage after primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction presenting early versus late after symptom onset
verfasst von
Thomas Stiermaier
Ingo Eitel
Suzanne de Waha
Janine Pöss
Georg Fuernau
Holger Thiele
Steffen Desch
Publikationsdatum
24.04.2017
Verlag
Springer Netherlands
Erschienen in
The International Journal of Cardiovascular Imaging / Ausgabe 10/2017
Print ISSN: 1569-5794
Elektronische ISSN: 1875-8312
DOI
https://doi.org/10.1007/s10554-017-1143-x

Weitere Artikel der Ausgabe 10/2017

The International Journal of Cardiovascular Imaging 10/2017 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.